Radiopharmaceuticals and Tracers

This channel includes news and new technology innovations for nuclear and molecular imaging agents, radiotracers and radiopharmaceuticals used in PET or SPECT imaging. This includes advances in myocardiac perfusion agents.

Blue Earth Diagnostics, U.S. headquarters, management expansion, PET imaging agent
News | Radiopharmaceuticals and Tracers | May 13, 2016

May 13, 2016 — Blue Earth Diagnostics, a molecular imaging diagnostics company, announced it has established...

News | Radiopharmaceuticals and Tracers | May 13, 2016

May 13, 2016 — NorthStar Medical Radioisotopes LLC is enhancing its production operations at the University of...

tau protein, Alzheimer's, PET scan, imaging agent, brain decline, Washington University in St. Louis

A study using a new PET imaging agent shows that measures of tau protein in the brain more closely track cognitive decline due to Alzheimer's disease compared with long-studied measures of amyloid beta. More red color indicates more tau protein. The image on the left shows the average tau accumulation in the brains of cognitively normal people, averaged over many individuals. The image on the right shows the average amount of tau buildup in the brains of multiple people with mild Alzheimer's symptoms. Scanning multiple individuals shows that the intensity of tau deposits correlates with the severity of cognitive dysfunction. Image courtesy of Matthew R. Brier.

News | PET Imaging | May 12, 2016

May 12, 2016 — A buildup of plaque and dysfunctional proteins in the brain are hallmarks of Alzheimer’s disease....

News | Radiopharmaceuticals and Tracers | May 11, 2016

May 11, 2016 — ITM (Isotopen Technologien München AG), a specialized radiopharmaceutical company, announced that the...

News | Radiopharmaceuticals and Tracers | May 09, 2016

May 9, 2016 — A recent study demonstrates that Ga-68 DOTATATE...

PET imaging, cancer treatment, UCLA study, Caius Radu, dCK
News | PET Imaging | March 29, 2016

March 29, 2016 —A promising new discovery by University of California Los Angeles (UCLA) scientists could lead to a...

IBA, sale, IBA Molecular, proton therapy, radiopharmaceuticals
News | Radiopharmaceuticals and Tracers | March 29, 2016

March 29, 2016 — IBA (Ion Beam Applications S.A.) announced the sale of IBA Molecular (IBAM) in which IBA had a 40...

MRI, fluorine tracer agent, UC San Diego, Eric Aherns
News | Magnetic Resonance Imaging (MRI) | March 14, 2016

March 14, 2016 — Writing in the March 14 online issue of Nature Materials, researchers at University of California,...

News | Radiopharmaceuticals and Tracers | March 01, 2016

March 1, 2016 — Wisconsin-based Shine Medical Technologies Inc., producer of medical tracers and cancer treatment...

Alzheimer's disease, oligomers, amyloid plaque, bifunctional chemical agents, Washington University in St. Louis
News | PET Imaging | February 23, 2016

February 23, 2016 — The National Institutes of Health recently bestowed a $1.5 million grant on a Washington...

Lymphoseek, cervical cancer study, MD Anderson, sentinel lymph node biopsy, SLNB
News | Radiopharmaceuticals and Tracers | February 18, 2016

February 18, 2016 — Navidea Biopharmaceuticals Inc. last week announced that the first patient has been enrolled in...

Weill Cornell Medicine, Senior Scientific, magnetix relaxometry, MRX technology, prostate cancer detection
News | Prostate Cancer | February 18, 2016

February 18, 2016 — Manhattan Scientifics Inc. announced its wholly-owned subsidiary Senior Scientific LLC, which is...

MEDraysintell, nuclear medicine, proton therapy, brachytherapy, global markets, 2030
News | Radiation Therapy | February 03, 2016

February 3, 2016 — The nuclear medicine, proton therapy and brachytherapy markets represent less than 0.1 percent of...

radiotracer, cancer imaging, diagnostics, PET, 18F-FLT
News | Oncology Diagnostics | January 29, 2016

January 29, 2016 — A biochemical compound developed as a...

News | Radiopharmaceuticals and Tracers | January 26, 2016

January 26, 2016 — University of Missouri researcher Silvia Jurisson and her interdisciplinary team recently...

prostate cancer, imaging agent, 64Cu-TP3805, PET/CT, Thomas Jefferson University study
News | Radiopharmaceuticals and Tracers | January 21, 2016

January 21, 2016 — Researchers at Thomas Jefferson University have found the method they developed to image the...

News | Prostate Cancer | December 18, 2015

Cancer Targeted Technology (CTT), a privately-held Seattle-based biotechnology firm focusing on cancer diagnostics...

Lymphoseek, RSNA 2015, clinical study, sentinel lymph node mapping, SLN

Image courtesy of Navidea Biopharmaceuticals

News | Oncology Diagnostics | December 11, 2015

December 11, 2015 — Navidea Biopharmaceuticals Inc. announced that results from an investigator-initiated imaging...

Minomic, MUH, first-in-human trial, novel prostate cancer imaging agent, MIL-38, Australia
News | Radiopharmaceuticals and Tracers | November 03, 2015

November 3, 2015 — Australian immuno-oncology company Minomic International Ltd has struck an agreement to launch...

Siemens PETNET Solutions, investigational PET molecular biomarker, prostate and breast cancer, PET/CT, PET/MR, NuView Life Sciences

Image courtesy of Philips

News | Radiopharmaceuticals and Tracers | October 19, 2015

October 19, 2015 — Siemens’ PETNET Solutions Inc., a wholly owned subsidiary of Siemens Healthcare, will formulate...